NewsRx

Search our medical news database

BioStratum Incorporated

Kirk Ways appointed VP, chief development officer at pharmaceutical firm

Published in Health Business Week, April 30th, 2004

BioStratum Incorporated announced that it has named Kirk Ways, MD, PhD, as VP and chief development officer.

Ways joins BioStratum from Aventis Pharmaceuticals where he held the position of senior global medical director and global project team leader. Prior to joining Aventis, Ways was a research advisor in the Lilly Research Laboratories with responsibility for the preclinical and clinical development of agents to treat the chronic complications of diabetes and was director of the Diabetes Center, professor, and vice chairman of the Department of Medicine at East Carolina University School of Medicine. An accomplished researcher, Ways has authored more than one...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook